MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call
MacroGenics, Inc.ROCKVILLE, MD, Feb. 27, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing...
























